Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cigna Group CI

The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. Evernorth Health Services includes a range of independent and coordinated health solutions and capabilities designed to enable the healthcare system to help people live richer, healthier lives. Health plans, employers, governmental organizations and health care providers partner with Evernorth Health Services to solve their challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. Cigna Healthcare includes the United States healthcare and international health businesses, which provide comprehensive medical and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI) and the Company's run-off operations.


NYSE:CI - Post by User

Bullboard Posts
Post by bc4uon Feb 07, 2013 9:41am
575 Views
Post# 20951337

CIGNA REPORTS STRONG FULL YEAR 2012 RESULTS, EXPEC

CIGNA REPORTS STRONG FULL YEAR 2012 RESULTS, EXPEC

CIGNA REPORTS STRONG FULL YEAR 2012 RESULTS, EXPECTS CONTINUED POSITIVE MOMENTUM FOR 2013

o Consolidated revenues for full year 2012 increased 33% to $29.1 billion.
o Adjusted income from operations1 for full year 2012 was $1.73 billion, or $5.99 per share,
which represents per share growth of 21% over 2011. Shareholders’ net income1 for full year
2012 was $1.62 billion, or $5.61 per share.
o Cigna's global medical customer base grew by 1.4 million people during 2012, reflecting strong
growth across our Commercial and Government businesses, including contributions from the
HealthSpring acquisition.
o The Company increased its outlook for full year 2013 consolidated adjusted income from
operations1,3 to be in the range of $1.7 billion to $1.83 billion, or $5.85 to $6.30 per share.

BLOOMFIELD, CT, February 7, 2013 – Cigna Corporation (NYSE: CI) today reported full year 2012
consolidated revenues of $29.1 billion, an increase of 33% over 2011. Revenues reflect growth in premiums and
fees of 38% from ongoing operations, primarily driven by contributions from the HealthSpring acquisition and
continued organic growth in targeted customer segments.
“Cigna's operating performance in 2012 was strong, driven by effective execution of our strategy and a
consistent focus on delivering value for our customers,” said David M. Cordani, President and Chief Executive
Officer. “This focus on our global customers and the disciplined management of our differentiated businesses
continues to drive our growth and positions Cigna well for attractive performance in 2013 and beyond.”
Cigna’s adjusted income from operations1 for full year 2012 was $1.73 billion, or $5.99 per share, compared with
$1.36 billion, or $4.96 per share, for full year 2011 which represents per share growth of 21% over 2011. For the
fourth quarter of 2012, adjusted income from operations1 was $452 million, or $1.57 per share, compared to $293
million, or $1.05 per share, for the fourth quarter of 2011.
Cigna reported full year 2012 shareholders’ net income1 of $1.62 billion, or $5.61 per share, compared with $1.26
billion, or $4.59 per share, for full year 2011. Shareholders’ net income1 included income of $29 million, or $0.10
per share, in 2012 and losses of $135 million, or $0.49 per share, in 2011 related to the Guaranteed Minimum
Income Benefits (GMIB)2,5 business within our Run-off Reinsurance segment. Shareholders’ net income1 also
included special items4 which resulted in losses of $171 million, or $0.59 per share, in 2012 compared to losses of
$7 million, or $0.03 per share, in 2011.
Cigna also reported fourth quarter 2012 shareholders’ net income1 of $406 million, or $1.41 per share, compared
with $273 million, or $0.98 per share, for the fourth quarter of 2011. Shareholders’ net income1 included income of
$7 million, or $0.02 per share, in the fourth quarter of 2012 and income of $7 million, or $0.03 per share, in the
same period of 2011 related to the Run-off GMIB2,5 business. Shareholders’ net income1 in the fourth quarter of
2012 also included special items4 which resulted in losses of $68 million, or $0.24 per share, related to litigation
matters, compared to losses of $31 million, or $0.11 per share, in the fourth quarter of 2011.

https://www.cigna.com/assets/docs/about-cigna/Investor%20Relations/CignaCorp_4Q12Release.pdf

Fourth Quarter 2012 Financial Supplement
https://www.cigna.com/assets/docs/about-cigna/Investor%20Relations/CignaCorp_4Q12QFS.pdf

Form 8-K: Announcing certain changes to Cigna's reporting segments
https://www.cigna.com/assets/docs/about-cigna/Investor%20Relations/cignacorp-form8k-1-24-2013.pdf

2012 Investor Day Presentation
https://www.cigna.com/assets/docs/about-cigna/Investor%20Relations/CignaCorp_2012InvestorDay.pdf

 


 

CI   Chart
https://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=&insttype=Stock&symb=ci&time=6&startdate=1%2F4%2F1999&enddate=1%2F8%2F2012&freq=1&compidx=aaaaa%3A0&comptemptext=&comp=&ma=4&maval=9+15+50&uf=7168&lf=1&lf2=4&lf3=2&type=4&style=320&size=3&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=0&y=0

Analyst Estimates
https://www.marketwatch.com/investing/stock/ci/analystestimates

Bullboard Posts